Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Filing tables
Filing exhibits
SEC
- 10-Q Quarterly report
- 31.1 Certifications Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certifications Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 Certifications Pursuant to 18 U.s.c. Section 1350 As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certifications Pursuant to 18 U.s.c. Section 1350 As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Coeptis Therapeutics similar filings
Filing view
EXHIBIT 32.2
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q for the period ended June 30, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 16, 2021 | /s/ Christine Sheehy |
| Christine Sheehy | |
| Chief Financial Officer, and Principal Financial and Accounting Officer |